After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking

7 trades

Disclosure transactions for Revelation Biosciences, Inc.
Reporting person Filed Transaction Transaction value Source Actions
Zygmont Chester Stanley Iii Chief Financial Officer Aug 18, 2026 1-day lag Award Aug 17, 2026 $0 Filed shares x price SEC Form 4 View filing
Chawla Lakhmir S Director Aug 18, 2026 1-day lag Award Aug 17, 2026 $0 Filed shares x price SEC Form 4 View filing
Roper Jess Director Aug 18, 2026 1-day lag Award Aug 17, 2026 $0 Filed shares x price SEC Form 4 View filing
Carver Jennifer Director Aug 18, 2026 1-day lag Award Aug 17, 2026 $0 Filed shares x price SEC Form 4 View filing
Zygmont Chester Stanley Iii Chief Financial Officer Aug 18, 2026 1-day lag Gift Aug 17, 2026 $0 Filed shares x price SEC Form 4 View filing
Rolke James Chief Executive Officer Aug 18, 2026 1-day lag Award Aug 17, 2026 $0 Filed shares x price SEC Form 4 View filing
Zygmont Chester Stanley Iii Chief Financial Officer Aug 18, 2026 1-day lag Gift Aug 17, 2026 $0 Filed shares x price SEC Form 4 View filing
Zygmont Chester Stanley Iii Chief Financial Officer
Award
Calculated transaction value
$0 208,073 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 18, 2026
Chawla Lakhmir S Director
Award
Calculated transaction value
$0 32,011 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 18, 2026
Roper Jess Director
Award
Calculated transaction value
$0 32,011 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 18, 2026
Carver Jennifer Director
Award
Calculated transaction value
$0 32,011 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 18, 2026
Zygmont Chester Stanley Iii Chief Financial Officer
Gift
Calculated transaction value
$0 208,073 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 18, 2026
Rolke James Chief Executive Officer
Award
Calculated transaction value
$0 208,076 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 18, 2026
Zygmont Chester Stanley Iii Chief Financial Officer
Gift
Calculated transaction value
$0 208,073 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 18, 2026